OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease…
OvaScienceSM and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, announced…
Read More...
Read More...
